Navigation Links
Environmental Tectonics Corporation's BioMedical Systems Division Announces First BARA-MED(R) Monoplace Hyperbaric Chamber Sale in Romania
Date:8/26/2009

SOUTHAMPTON, Pa., Aug. 26 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") BioMedical Systems Division, a product division in ETC's Controls Systems Group, has contracted with Histria International, SRL for the delivery and installation of the first BARA-MED((R)) computerized monoplace hyperbaric chamber in Romania.

Histria International is a "turn-key" supplier, providing all the necessary facilities of a comprehensive investment project regardless of its application - industrial, office, commercial, residential - and providing the human resources and logistics necessary for the work on the site. They support both standard products and custom technical solutions, depending on project specifications

Hyperbaric Oxygen Therapy (HBOT) is a technique of administering 100% oxygen at greater than one atmospheric (ATA) pressure to a patient in order to improve or correct conditions. Providing oxygen in a pressurized chamber can deliver 10-15 times more oxygen then if delivered at sea level or at normal atmospheric levels. HBOT is used to promote and support healing in the management of conditions in which oxygen transport to the tissues has been disrupted by traumatic injury, infection, inflammation, or edema. HBOT is used to complement conventional therapies and treatments.

ETC is the manufacturer of the BARA-MED((R)) and BARA-MED((R)) XD, computerized monoplace hyperbaric chambers. Our Operating System for Control And Recordkeeping (O.S.C.A.R.(TM)) is the integrated computerized basis of our monoplace hyperbaric chambers based on a 4th generation time-proven Windows(TM) operating system.

The O.S.C.A.R.(TM) operating system produces a comprehensive Electronic Medical Record (EMR) of each HBOT treatment. This automated system eliminates the need for operator dive time management and paper recordkeeping while ensuring comprehensive documentation of the treatment.

Dave Mitchell, Vice President of Controls Systems Groups Sales, stated, "The hyperbaric chamber market is one of the emerging markets in the world. Currently we have chambers in 22 countries world wide. We are proud to develop this relationship with Histria International and look forward to working with them on additional installations."

ETC was incorporated in 1969 in Pennsylvania and this year we will celebrate our 40th anniversary. Our core technologies include the design, manufacture and sale of Training Services (TSG) which includes (1) software driven products and services used to create and monitor the physiological effects of flight; (2) high performance jet tactical flight simulation, and; (3) driving and disaster simulation systems, and Control Systems (CSG) which includes: (1) steam and gas sterilization; (2) testing and simulation devices for the automotive industry, and; (3) hyperbaric and hypobaric chambers. Product categories included in TSG are Aircrew Training Systems (ATS) and flight simulators, disaster management systems and entertainment applications. CSG includes sterilizers, environmental control devices and hyperbaric chambers along with parts and service support.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are based on ETC's current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

These forward-looking statements include statements with respect to the Company's vision, mission, strategies, goals, beliefs, plans, objectives, expectations, anticipations, estimates, intentions, financial condition, results of operations, future performance and business of the company, including but not limited to, (i) potential additional funding by H.F. Lenfest, a member of our Board of Directors and a significant shareholder, and PNC Bank, (ii) the trading of the Company's common stock on the Over-the-Counter Bulletin Board (iii) projections of revenues, costs of materials, income or loss, earnings or loss per share, capital expenditures, growth prospects, dividends, capital structure, other financial items and the effects of currency fluctuations, (iv) statements of our plans and objectives of the Company or its management or Board of Directors, including the introduction of new products, or estimates or predictions of actions of customers, suppliers, competitors or regulatory authorities, (v) statements of future economic performance, (vi) statements of assumptions and other statements about the Company or its business, (vii) statements made about the possible outcomes of litigation involving the Company, (viii) statements regarding the Company's ability to obtain financing to support its operations and other expenses, and (ix) statements preceded by, followed by or that include the words, "may," "could," "should," "looking forward," "would," "believe," "expect," "anticipate," "estimate," "intend," "plan," or the negative of such terms or similar expressions. These forward-looking statements involve risks and uncertainties which are subject to change based on various important factors. Some of these risks and uncertainties, in whole or in part, are beyond the Company's control. Factors that might cause or contribute to such a material difference include, but are not limited to, those discussed in the Company's Annual Report on Form 10K for the fiscal year ended February 27, 2009, in the section entitled "Risks Particular to Our Business." Shareholders are urged to review these risks carefully prior to making an investment in the Company's common stock.

The Company cautions that the foregoing list of important factors is not exclusive. Except as required by federal securities law, the Company does not undertake to update any forward-looking statement, whether written or oral, that may be made from time to time by or on behalf of the Company.

    Contact: Duane D. Deaner, CFO
    Tel: 215-355-9100 (ext. 1203)
    Fax: 215-357-4000
    ETC - Internet Home Page:    http://www.etcusa.com


'/>"/>
SOURCE Environmental Tectonics Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. ICBS to focus on pharmaceutical and environmental markets
2. Health and Environmental Groups Announce Intent to Sue Illinois Coal Plant Owners for Violating Clean Air Act
3. Health Care Without Harm Partners With Clinton Climate Initiative to Help Hospitals and Healthcare Facilities Reduce Environmental Impact
4. Miller-McCune Magazine Wins Environmental Journalism Prize
5. Grupo Salinas, Fundacion Azteca and Mexicos Environmental Ministry Present Ciudades Mas Limpias de Mexico and Recicla 2009 Anti-Litter and Recycling Contests
6. Environmental manganese good in trace amounts but can correlate to cancer rates
7. IBM Award for Innovative Solution to Tackling Worlds Most Critical Social and Environmental Problems
8. Startech Environmental Advises Shareholders to Take No Action in Response to Friendly LRL Tender Offer
9. Researchers find possible environmental causes for Alzheimers, diabetes
10. CDCs National Center for Environmental Health Works with Thomson Reuters to Help Identify and Track Illnesses Related to Harmful Algal Blooms
11. xpedx Shows U.S. Property Managers and Owners How to Achieve Building Health and Environmental Goals Without Increasing Total Cleaning Costs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 27, 2017 , ... EpiGentek , a Farmingdale, NY-based ... RNA methylation “gold rush” with their established portfolio of optimized assay kits that ... or m6A , RNA methylation has received a new burst in interest ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association ... chain professionals, will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. ... “Increasingly, supply chain and value analysis professionals have a ‘seat at the table’ ...
(Date:3/27/2017)... Angeles, CA (PRWEB) , ... March 27, 2017 , ... ... men with prostate cancer, including all stages, is more than 95%. Once the cancer ... drastically to less than 30%. To find out how to avoid this latter group, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... sodium testing methods are complicated and require expert user knowledge. In a live ... method dedicated to the simplified, yet highly accurate, determination of sodium. , It ...
(Date:3/27/2017)... ... 2017 , ... ?Grow Healthy Vending LLC announced today that ... itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ United States ... that we have now reached a settlement agreement regarding the ongoing lawsuits between ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... Calif. , March 27, 2017  Sanderling ... acquired by Ethicon, a division of Johnson & ... System for the treatment of gastro-esophageal reflux disease ... sphincter augmentation (MSA) technology and the procedure is ... centers. Torax Medical was founded by ...
(Date:3/27/2017)... Israel , March 27, 2017 ... oncology and immunology, announced today that AGI-134, an immunotherapy for ... acquisition of Agalimmune Ltd., will be featured at the upcoming ... in Washington, DC to be held ... ...
(Date:3/27/2017)... 27, 2017 The global ... 16.0 billion by 2025, according to a new study ... chronic diseases is anticipated to be responsible for the ... widens the scope for growth during the forecast period. ... which is highly susceptible to chronic diseases, is presumed ...
Breaking Medicine Technology: